- Home
- EYEN vs STRW Comparison
EYEN vs STRW Comparison
Compare EYEN & STRW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EYEN
- STRW
- Stock Information
- Founded
- EYEN 2014
- STRW 2015
- Country
- EYEN United States
- STRW United States
- Employees
- EYEN N/A
- STRW N/A
- Industry
- EYEN Biotechnology: Pharmaceutical Preparations
- STRW Real Estate Investment Trusts
- Sector
- EYEN Health Care
- STRW Real Estate
- Exchange
- EYEN Nasdaq
- STRW Nasdaq
- Market Cap
- EYEN 38.2M
- STRW 79.7M
- IPO Year
- EYEN 2018
- STRW N/A
- Fundamental
- Price
- EYEN $0.55
- STRW $12.52
- Analyst Decision
- EYEN Strong Buy
- STRW Strong Buy
- Analyst Count
- EYEN 2
- STRW 1
- Target Price
- EYEN $12.00
- STRW $10.00
- AVG Volume (30 Days)
- EYEN 879.0K
- STRW 14.4K
- Earning Date
- EYEN 11-11-2024
- STRW 11-11-2024
- Dividend Yield
- EYEN N/A
- STRW 4.11%
- EPS Growth
- EYEN N/A
- STRW N/A
- EPS
- EYEN N/A
- STRW 0.47
- Revenue
- EYEN $31,405.00
- STRW $108,357,000.00
- Revenue This Year
- EYEN $50,309.30
- STRW N/A
- Revenue Next Year
- EYEN $421.63
- STRW N/A
- P/E Ratio
- EYEN N/A
- STRW $27.19
- Revenue Growth
- EYEN N/A
- STRW 12.45
- 52 Week Low
- EYEN $0.37
- STRW $6.56
- 52 Week High
- EYEN $2.57
- STRW $12.90
- Technical
- Relative Strength Index (RSI)
- EYEN 52.60
- STRW 62.39
- Support Level
- EYEN $0.52
- STRW $11.57
- Resistance Level
- EYEN $0.59
- STRW $12.36
- Average True Range (ATR)
- EYEN 0.05
- STRW 0.32
- MACD
- EYEN 0.01
- STRW 0.05
- Stochastic Oscillator
- EYEN 66.45
- STRW 93.10
About EYEN Eyenovia Inc.
Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations.
About STRW Strawberry Fields REIT Inc.
Strawberry Fields REIT Inc is a self-managed and self-administered company that specializes in the acquisition, ownership and triple-net leasing of skilled nursing facilities and other post-acute healthcare properties.